Analysis of Novel Positioning Sensor-assisted Postoperative Position Correction and Effective Prone Time Recorded in Patients With Different Prone Times After Macular Hole Surgery

Idiopathic Macular Hole Clinical Trial

Official title:

A Prospective Study on the Prognosis of the Idiopathic Macular Hole With Different Prone Position Times Assisted by Novel Positioning Sensor

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05757349
• Other study ID #: TianjinMUEHhbj456
• Status: Recruiting
• Phase: N/A
• Start date: October 1, 2022
• Est. completion date: March 30, 2024

Study information

• Verified date: February 2023
• Source: Tianjin Medical University Eye Hospital
• Contact: Bojie Hu
• Phone: 13612130943
• Email: bhu07[@]tmu.edu.cn
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Idiopathic macular hole (IMH) is a fundus disease without clear etiology, most often seen in healthy women over 50 years of age, and is often associated with ocular manifestations such as loss of central vision and visual distortion. It is often associated with loss of central vision, visual distortion, and other ocular manifestations. It is currently treated by vitrectomy combined with internal limiting membranes (ILM) peeling followed by gas filling. A strict prone position for a certain period of time after surgery has a positive effect on the healing of the macular fissure. The need for a strict prone position after IMH has been demonstrated in previous studies (especially when the IMH diameter is >400 μm). However, due to the anti-human mechanics of the face-down position, patient comfort, sleep quality and quality of life are greatly compromised. Therefore, this study designed a smart head position monitoring device to assist patients in maintaining the correct position and recording the effective position time. The study was conducted to determine the shortest prone position time based on macular fissure closure, to minimize the adverse effects of postoperative position, and to obtain the maximum recovery of visual acuity and visual field.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 86
• Est. completion date: March 30, 2024
• Est. primary completion date: March 30, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients aged 18 years or older;
• Patients diagnosed with IMH;
• Patients requiring face-down position after vitrectomy combined with ILM peeling and C3F8(14%) gas filling; Tolerated face-down position after surgery;
• Agreed to the study protocol.

Exclusion Criteria:

• Myopia greater than or equal to -6.0 D; Eye axis length (AL) greater than 26.0mm;
• Trauma, macular edema, macular degeneration, and other secondary MH with clear etiology;
• Previous history of internal eye surgery in the operated eye;
• Patients with local or systemic other diseases significantly affecting visual function;
• Those who cannot maintain face-down position after surgery due to systemic factors, etc.

Related Conditions & MeSH terms

• Idiopathic Macular Hole
• Retinal Perforations

Intervention

Behavioral:
• Face-down position time 1-day
Postoperative face-down position of subjects wearing the novel positioning sensor device for 1-day.
• Face-down position time 3-day
Postoperative face-down position of subjects wearing the novel positioning sensor device for 3-day.

Locations

Country	Name	City	State
China	Tianjin medical university eye hosipital	Tianjin	Tianjin

Sponsors (1)

Lead Sponsor	Collaborator
Tianjin Medical University Eye Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Macular hole closure rate	Ratio of patients with postoperative lacunae that remained closed until the end of the follow-up time to the number of patients who reopened during the follow-up time of those who did not close after surgery	6 month postoperatively
Primary	Effective face-down position time	Novel positioning sensor related data cloud storage platform can record and extract effective face-down position time.	1 or 3 day postoperatively
Secondary	Best corrected visual acuity change (BCVA)	BCVA for patients after macular fissure surgery, expressed using the (ETDRS) Alphabet Chart.	1, 3, 6 month postoperatively
Secondary	Retinal nerve fiber layer thickness change	Three-dimensional spectral domain optical coherence tomography (SD-OCT)	1, 3, 6 month postoperatively
Secondary	Macular ganglion cell complex thickness change (GCL+, GCL++)	Three-dimensional spectral domain optical coherence tomography (SD-OCT)	1, 3, 6 month postoperatively
Secondary	Mean retinal Sensitivity (MS)	Micro Perimeter 3	1, 3, 6 month postoperatively
Secondary	Central 2° and 4° fixation	Micro Perimeter 3	1, 3, 6 month postoperatively